TECX
Tectonic Therapeutic, Inc.
-0.28 (-1.00%)27.63USD44.5K成交股數540M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 3 · 9K · 1 |
| 其中 10b5-1 計畫賣出 | 3 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 72K |
| 近 180 天 淨額 | −72K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | 08-26 | McNamara Peter | Chief Scientific Officer | M 選擇權執行 | 43 | 14.71 | 632.53 | 55.3K | SEC |
| 2026-08-25 | 08-26 | McNamara Peter | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 43 | 36.52 | 2K | 55.3K | SEC |
| 2026-08-12 | 08-14 | McNamara Peter | Chief Scientific Officer | M 選擇權執行 | 43 | 14.71 | 632.53 | 55.3K | SEC |
| 2026-08-12 | 08-14 | McNamara Peter | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 43 | 35.00 | 2K | 55.3K | SEC |
| 2026-06-30 | 07-01 | McNamara Peter | Chief Scientific Officer | M 選擇權執行 | 172 | 14.71 | 3K | 55.5K | SEC |
| 2026-06-30 | 07-01 | McNamara Peter | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 172 | 35.00 | 6K | 55.3K | SEC |
| 2026-06-20 | 06-23 | REICIN ALISE | Chief Executive Officer | F 繳稅扣股 | 924 | 30.34 | 28K | 311K | SEC |
| 2026-05-04 | 05-06 | Ruddy Marcella K. | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.1K | 30.00 | 32K | 67.7K | SEC |
| 2026-04-01 | 04-03 | Ruddy Marcella K. | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.0K | 31.05 | 31K | 68.7K | SEC |
| 2026-03-06 | 03-09 | Ruddy Marcella K. | Chief Medical Officer | S 公開市場賣出(10b5-1) | 10.0K | 30.00 | 300K | 69.7K | SEC |
| 2026-03-06 | 03-09 | McNamara Peter | Chief Scientific Officer | M 選擇權執行 | 2.5K | 2.38 | 6K | 61.3K | SEC |
| 2026-03-06 | 03-09 | McNamara Peter | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 215 | 35.00 | 8K | 55.3K | SEC |
| 2026-03-06 | 03-09 | McNamara Peter | Chief Scientific Officer | M 選擇權執行 | 215 | 14.71 | 3K | 61.5K | SEC |
| 2026-03-06 | 03-09 | McNamara Peter | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.0K | 30.00 | 181K | 55.5K | SEC |
| 2026-03-04 | 03-05 | Ruddy Marcella K. | Chief Medical Officer | A 獲配股票 | 26.5K | – | – | 79.7K | SEC |
| 2026-03-04 | 03-05 | McNamara Peter | Chief Scientific Officer | A 獲配股票 | 23.0K | – | – | 60.5K | SEC |
| 2026-03-04 | 03-05 | McNamara Peter | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.6K | 25.00 | 41K | 58.8K | SEC |
| 2026-03-04 | 03-05 | Lochner Daniel | Chief Financial Officer | A 獲配股票 | 26.5K | – | – | 58.5K | SEC |
| 2026-03-04 | 03-05 | Schwabish Marc | Chief Business Officer | A 獲配股票 | 19.5K | – | – | 45.3K | SEC |
| 2026-03-04 | 03-05 | REICIN ALISE | Chief Executive Officer | A 獲配股票 | 76.5K | – | – | 312K | SEC |
| 2026-03-03 | 03-05 | McNamara Peter | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.6K | 22.06 | 36K | 37.5K | SEC |
| 2026-02-11 | 03-05 | REICIN ALISE | Chief Executive Officer | P 公開市場買進 | 2.5K | 21.10 | 53K | 127K | SEC |
| 2026-02-11 | 02-12 | REICIN ALISE | Chief Executive Officer | P 公開市場買進 | 2.5K | 21.10 | 53K | 238K | SEC |
| 2026-02-10 | 02-12 | Schwabish Marc | Chief Business Officer | M 選擇權執行 | 4.5K | 2.38 | 11K | 25.8K | SEC |
| 2026-02-10 | 02-11 | Lochner Daniel | Chief Financial Officer | P 公開市場買進 | 6.0K | 21.61 | 130K | 32.0K | SEC |
| 2026-02-04 | 02-10 | Schwabish Marc | Chief Business Officer | F 繳稅扣股 | 1.6K | 23.22 | 38K | 21.3K | SEC |
| 2026-02-04 | 02-10 | Lochner Daniel | Chief Financial Officer | F 繳稅扣股 | 2.1K | 23.22 | 48K | 26.0K | SEC |
| 2026-02-04 | 02-10 | McNamara Peter | Chief Scientific Officer | F 繳稅扣股 | 1.7K | 23.22 | 41K | 39.1K | SEC |
| 2026-02-04 | 02-10 | REICIN ALISE | Chief Executive Officer | F 繳稅扣股 | 4.1K | 23.22 | 95K | 235K | SEC |
| 2026-02-04 | 02-10 | Ruddy Marcella K. | Chief Medical Officer | F 繳稅扣股 | 2.1K | 23.22 | 48K | 53.2K | SEC |
| 2025-12-31 | 01-05 | REICIN ALISE | Chief Executive Officer | M 選擇權執行 | 11.0K | 2.38 | 26K | 239K | SEC |
| 2025-12-22 | 12-29 | McNamara Peter | Chief Scientific Officer | M 選擇權執行 | 7.0K | 2.98 | 21K | 40.9K | SEC |
| 2025-09-25 | 09-29 | Schwabish Marc | Chief Business Officer | A 獲配股票 | 4.2K | – | – | 22.9K | SEC |
| 2025-09-25 | 09-29 | Lochner Daniel | Chief Financial Officer | A 獲配股票 | 5.4K | – | – | 28.1K | SEC |
| 2025-09-25 | 09-29 | Ruddy Marcella K. | Chief Medical Officer | A 獲配股票 | 5.4K | – | – | 55.3K | SEC |
| 2025-09-25 | 09-29 | REICIN ALISE | Chief Executive Officer | A 獲配股票 | 14.7K | – | – | 228K | SEC |
| 2025-09-25 | 09-29 | McNamara Peter | Chief Scientific Officer | A 獲配股票 | 4.5K | – | – | 33.9K | SEC |
| 2025-06-20 | 06-24 | REICIN ALISE | Chief Executive Officer | F 繳稅扣股 | 859 | 19.81 | 17K | 213K | SEC |
| 2025-04-11 | 04-11 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 53.7K | 16.31 | 876K | 1.5M | SEC |
| 2025-04-11 | 04-11 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 9.5K | 16.31 | 155K | 4.3M | SEC |
| 2025-04-10 | 04-11 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 45.9K | 16.73 | 767K | 1.4M | SEC |
| 2025-04-10 | 04-11 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 8.1K | 16.73 | 135K | 4.3M | SEC |
| 2025-04-09 | 04-11 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 4.9K | 15.23 | 74K | 1.4M | SEC |
| 2025-04-09 | 04-11 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 16.2K | 14.62 | 237K | 1.4M | SEC |
| 2025-04-09 | 04-11 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 857 | 15.23 | 13K | 4.3M | SEC |
| 2025-04-09 | 04-11 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 2.9K | 14.62 | 42K | 4.3M | SEC |
| 2025-04-07 | 04-09 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 413K | 17.10 | 7.1M | 1.4M | SEC |
| 2025-04-07 | 04-09 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 87.5K | 17.10 | 1.5M | 4.3M | SEC |
| 2025-04-07 | 04-07 | MCGUIRE TERRANCE | Director | S 公開市場賣出 | 500K | 17.10 | 8.6M | 573K | SEC |
| 2025-02-05 | 02-07 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 660K | 50.00 | 33.0M | 970K | SEC |
| 2025-02-05 | 02-07 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 129K | 54.14 | 7.0M | 4.2M | SEC |
| 2025-02-05 | 02-07 | Lochner Daniel | Chief Financial Officer | P 公開市場買進 | 4.6K | 54.14 | 250K | 4.6K | SEC |
| 2025-02-04 | 02-06 | REICIN ALISE | Chief Executive Officer | A 獲配股票 | 36.0K | – | – | 214K | SEC |
| 2025-02-04 | 02-06 | Schwabish Marc | Chief Business Officer | A 獲配股票 | 14.0K | – | – | 18.7K | SEC |
| 2025-02-04 | 02-06 | McNamara Peter | Chief Scientific Officer | A 獲配股票 | 15.1K | – | – | 29.3K | SEC |
| 2025-02-04 | 02-06 | Ruddy Marcella K. | Chief Medical Officer | A 獲配股票 | 17.9K | – | – | 49.9K | SEC |
| 2025-02-04 | 02-06 | Lochner Daniel | Chief Financial Officer | A 獲配股票 | 18.1K | – | – | 18.1K | SEC |
| 2025-01-28 | 01-29 | Schwabish Marc | Chief Business Officer | M 選擇權執行 | 2.7K | 2.38 | 6K | 4.7K | SEC |
| 2024-12-09 | 12-11 | Schwabish Marc | Chief Business Officer | M 選擇權執行 | 2.0K | 2.38 | 5K | 2.0K | SEC |
| 2024-12-04 | 12-06 | REICIN ALISE | Chief Executive Officer | A 獲配股票 | 11.7K | – | – | 178K | SEC |
| 2024-12-03 | 12-05 | McNamara Peter | Chief Scientific Officer | M 選擇權執行 | 3.5K | 2.38 | 8K | 14.2K | SEC |
| 2024-10-22 | 10-24 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 300K | 33.59 | 10.1M | 4.1M | SEC |
| 2024-09-26 | 09-26 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 24.5K | 28.16 | 691K | 3.8M | SEC |
| 2024-09-26 | 09-26 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 2.4K | 30.87 | 74K | 3.8M | SEC |
| 2024-09-26 | 09-26 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 19.0K | 29.13 | 553K | 3.8M | SEC |
| 2024-09-26 | 09-26 | SPRINGER TIMOTHY A | Director,TenPercentOwner | P 公開市場買進 | 4.1K | 30.10 | 123K | 3.8M | SEC |
| 2024-09-24 | 09-26 | SPRINGER TIMOTHY A | Director,TenPercentOwner | J 其他 | 1.2M | – | – | 310K | SEC |
| 2024-09-24 | 09-26 | SPRINGER TIMOTHY A | Director,TenPercentOwner | J 其他 | 186K | – | – | 186K | SEC |
| 2024-09-24 | 09-26 | SPRINGER TIMOTHY A | Director,TenPercentOwner | J 其他 | 1.1M | – | – | 3.7M | SEC |
| 2024-06-20 | 06-25 | Leonard Braden Michael | Other | J 其他 | 33.3K | – | – | 33.3K | SEC |
| 2024-06-20 | 06-25 | Leonard Braden Michael | Other | J 其他 | 400K | – | – | 400K | SEC |
| 2024-06-20 | 06-24 | SPRINGER TIMOTHY A | Director,TenPercentOwner | A 獲配股票 | 2.7M | – | – | 2.7M | SEC |
| 2024-06-20 | 06-24 | MCGUIRE TERRANCE | Director | A 獲配股票 | 20.3K | – | – | 20.3K | SEC |
| 2024-06-20 | 06-24 | MCGUIRE TERRANCE | Director | A 獲配股票 | 1.1M | – | – | 1.1M | SEC |
| 2024-06-20 | 06-24 | Ruddy Marcella K. | Chief Medical Officer | A 獲配股票 | 32.1K | – | – | 32.1K | SEC |
| 2024-06-20 | 06-24 | McNamara Peter | Chief Scientific Officer | A 獲配股票 | 10.7K | – | – | 10.7K | SEC |
| 2024-06-20 | 06-24 | Cortis Christian | Chief Operating Officer | A 獲配股票 | 126K | – | – | 126K | SEC |
| 2024-06-20 | 06-24 | MCGUIRE TERRANCE | Director | A 獲配股票 | 64.7K | – | – | 64.7K | SEC |
| 2024-06-20 | 06-24 | REICIN ALISE | Chief Executive Officer | A 獲配股票 | 125K | – | – | 125K | SEC |
| 2024-06-20 | 06-24 | REICIN ALISE | Chief Executive Officer | A 獲配股票 | 167K | – | – | 167K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 2.8M | 97.3M | 新進 | 新進 |
| TCG Crossover Management, LLC | 1.2M | 41.4M | 新進 | 新進 |
| Aberdeen Group plc | 1.1M | 39.3M | 新進 | 新進 |
| BlackRock, Inc. | 863K | 29.7M | 新進 | 新進 |
| First Light Asset Management, LLC | 801K | 27.5M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 608K | 20.9M | 新進 | 新進 |
| 5AM Venture Management, LLC | 607K | 20.9M | 新進 | 新進 |
| BRAIDWELL LP | 597K | 20.5M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 489K | 16.8M | 新進 | 新進 |
| Vestal Point Capital, LP | 425K | 14.6M | 新進 | 新進 |
| KENNEDY CAPITAL MANAGEMENT LLC | 282K | 9.7M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 270K | 9.3M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 227K | 7.8M | 新進 | 新進 |
| STATE STREET CORP | 220K | 7.6M | 新進 | 新進 |
| Ikarian Capital, LLC | 206K | 7.1M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 187K | 6.4M | 新進 | 新進 |
| MARSHALL WACE, LLP | 172K | 5.9M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 166K | 5.7M | 新進 | 新進 |
| Squarepoint Ops LLC | 145K | 5.0M | 新進 | 新進 |
| AMERIPRISE FINANCIAL INC | 142K | 4.9M | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 117K | 4.0M | 新進 | 新進 |
| NORTHERN TRUST CORP | 114K | 3.9M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 102K | 3.5M | 新進 | 新進 |
| Woodline Partners LP | 100K | 3.4M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 94.4K | 3.2M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 123 +12 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 123 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 14.0M · 71.4% |
| 合計季末市值 | 466M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 1.9M |
|---|---|
| 與上期比 | +12.5% |
| 佔流通股數 | 9.94% |
| 日均成交量 | 256K |
| 回補天數 | 7.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 1.9M | +12.5% | 9.94% | 256K | 7.6 |
| 2026-08-14 | 1.7M | -2.1% | 8.83% | 205K | 8.4 |
| 2026-07-31 | 1.8M | -8.9% | 9.03% | 164K | 10.8 |
| 2026-07-15 | 1.9M | -9.4% | 9.91% | 256K | 7.6 |
| 2026-06-30 | 2.1M | -0.7% | 10.93% | 149K | 14.3 |
| 2026-06-15 | 2.2M | -8.1% | 11.01% | 129K | 16.7 |
| 2026-05-29 | 2.3M | -10.4% | 11.98% | 221K | 10.6 |
| 2026-05-15 | 2.6M | +6.5% | 13.36% | 255K | 10.2 |
| 2026-04-30 | 2.5M | +1.2% | 12.55% | 225K | 10.9 |
| 2026-04-15 | 2.4M | +0.5% | 12.40% | 179K | 13.6 |
| 2026-03-31 | 2.4M | -13.6% | 12.35% | 191K | 12.6 |
| 2026-03-13 | 2.8M | -9.6% | 14.29% | 467K | 6.0 |
| 2026-02-27 | 3.1M | -15.4% | 15.81% | 286K | 10.8 |
| 2026-02-13 | 3.7M | -3.0% | 18.70% | 829K | 4.4 |
| 2026-01-30 | 3.8M | -5.3% | 19.28% | 230K | 16.4 |
| 2026-01-15 | 4.0M | +6.3% | 20.35% | 220K | 18.1 |
| 2025-12-31 | 3.7M | -30.1% | 19.13% | 385K | 9.7 |
| 2025-12-15 | 5.4M | +5.2% | 27.38% | 253K | 21.2 |
| 2025-11-28 | 5.1M | +1.7% | 26.04% | 350K | 14.5 |
| 2025-11-14 | 5.0M | +3.8% | 25.60% | 524K | 9.6 |
| 2025-10-31 | 4.8M | +35.8% | 24.68% | 759K | 6.4 |
| 2025-10-15 | 3.6M | +24.7% | 18.18% | 481K | 7.4 |
| 2025-09-30 | 2.8M | +17.8% | 14.58% | 568K | 5.0 |
| 2025-09-15 | 2.4M | -6.5% | 12.37% | 812K | 3.0 |
| 2025-08-29 | 2.6M | +3.0% | 13.23% | 124K | 20.9 |
| 2025-08-15 | 2.5M | +15.6% | 12.85% | 252K | 10.0 |